These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The response to procainamide during electrophysiologic study for sustained ventricular tachyarrhythmias predicts the response to other medications. Waxman HL, Buxton AE, Sadowski LM, Josephson ME. Circulation; 1983 Jan; 67(1):30-7. PubMed ID: 6847803 [Abstract] [Full Text] [Related]
5. [Electrophysiological evaluation of the treatment of patients with recurrent ventricular tachycardia]. Mendoza I, Moleiro F, Castellanos A, Casal H, Arends E, Medina V. Arch Inst Cardiol Mex; 1982 Jan; 52(4):301-11. PubMed ID: 7138133 [Abstract] [Full Text] [Related]
6. Antiarrhythmic drug combinations in the treatment of ventricular tachycardia. Ross DL, Sze DY, Keefe DL, Swerdlow CD, Echt DS, Griffin JC, Winkle RA, Mason JW. Circulation; 1982 Dec; 66(6):1205-10. PubMed ID: 6814784 [Abstract] [Full Text] [Related]
9. Effects of intravenous disopyramide and quinidine on normal myocardium and on the characteristics of arrhythmias: intraindividual comparison in patients with sustained ventricular tachycardia. Rizos I, Brachmann J, Lengfelder W, Schmitt C, von Olshausen K, Kübler W, Senges J. Eur Heart J; 1987 Feb; 8(2):154-63. PubMed ID: 3569310 [Abstract] [Full Text] [Related]
11. Drug-induced narrowing of the width of the zone of entrainment as a predictor of the subsequent non-inducibility of reentrant ventricular tachycardia after an additional dose of an antiarrhythmic drug. Aizawa Y, Chinushi M, Naitoh N, Shibata A. Heart; 1996 Feb; 75(2):165-70. PubMed ID: 8673755 [Abstract] [Full Text] [Related]
14. Long-term efficacy of mexiletine alone and in combination with class Ia antiarrhythmic drugs for refractory ventricular arrhythmias. Whitford EG, McGovern B, Schoenfeld MH, Garan H, Newell JB, McElroy M, Ruskin JN. Am Heart J; 1988 Feb; 115(2):360-6. PubMed ID: 3341170 [Abstract] [Full Text] [Related]
15. Antiarrhythmic drug therapy for sustained ventricular tachycardia. Kienzle MG, Williams PD, Zygmont D, Doherty JU, Josephson ME. Heart Lung; 1984 Nov; 13(6):614-22. PubMed ID: 6149202 [Abstract] [Full Text] [Related]
16. Evaluation of lorcainide in patients with symptomatic ventricular tachycardia. Somberg JC, Butler B, Flowers D, Keefe D, Torres V, Miura D. Am J Cardiol; 1984 Aug 13; 54(4):43B-48B. PubMed ID: 6465046 [Abstract] [Full Text] [Related]
17. Relative efficacy and safety of intravenous drugs for termination of sustained ventricular tachycardia. Griffith MJ, Linker NJ, Garratt CJ, Ward DE, Camm AJ. Lancet; 1990 Sep 15; 336(8716):670-3. PubMed ID: 1975861 [Abstract] [Full Text] [Related]
18. Electropharmacologic testing in sustained ventricular tachycardia associated with coronary heart disease: value of the response to intravenous procainamide in predicting the response to oral procainamide and oral quinidine treatment. Oseran DS, Gang ES, Rosenthal ME, Mandel WJ, Peter T. Am J Cardiol; 1985 Nov 15; 56(13):883-6. PubMed ID: 3904387 [Abstract] [Full Text] [Related]
19. The efficacy of cibenzoline and propafenone against inducible sustained and nonsustained ventricular tachycardias in conscious dogs with isolated chronic right ventricular infarction: a comparative study with procainamide. Karagueuzian HS, Sugi K, Ohta M, Meesmann M, Ino T, Peter T, Mandel WJ. Am Heart J; 1986 Dec 15; 112(6):1173-83. PubMed ID: 3788764 [Abstract] [Full Text] [Related]
20. Effectiveness of propranolol added to a type I antiarrhythmic agent for sustained ventricular tachycardia secondary to coronary artery disease. Friehling TD, Lipshutz H, Marinchak RA, Stohler JL, Kowey PR. Am J Cardiol; 1990 Jun 01; 65(20):1328-33. PubMed ID: 2343820 [Abstract] [Full Text] [Related] Page: [Next] [New Search]